Logo

American Heart Association

  2
  0


Final ID:

Mixed Group 2/3 and Group 3/2 Pulmonary Hypertension: Lessons Learned from PVDOMICS

  • Hemnes, Anna  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Leopold, Jane  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Rischard, Franz  ( The University of Arizona , Tucson , Arizona , United States )
  • Author Disclosures:
    Anna Hemnes: DO have relevant financial relationships ; Consultant:GossamerBio:Active (exists now) ; Consultant:Bayer:Past (completed) ; Consultant:United Therapeutics:Active (exists now) ; Individual Stocks/Stock Options:Tenax Therapeutics:Active (exists now) ; Consultant:Tenax Therapeutics:Past (completed) ; Consultant:Janssen:Active (exists now) ; Consultant:Merck:Active (exists now) | Jane Leopold: DO NOT have relevant financial relationships | Franz Rischard: DO have relevant financial relationships ; Researcher:United Therapeutics:Active (exists now) ; Researcher:Bayer:Active (exists now) ; Researcher:Merck:Active (exists now) ; Researcher:Respira:Active (exists now) ; Researcher:Aerovate:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Mixing it Up: Pulmonary Hypertension in Patients with Both Heart and Lung Disease

Monday, 11/18/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available